Delivery Order SPE2DB20D3103-SPE2DB25FP8Y6
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,775.01 delivery order to AmerisourceBergen Drug Corp for Capecitabine 500 mg tablets (120-count) on April 23, 2025, with completion scheduled for April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing under a delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Capecitabine 150 mg tablets. The contract, valued at $1,094.60, has a period of performance through May 18, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,099.40, is for the delivery of 4565391944 CAPECITABINE 500 MG TABLET 120S. The contract has an ultimate completion date of August 9, 2024 and is a Firm Fixed Price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 15, 2025, for the supply of Xalkori 250 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $14,356.89. This non-set-aside competitive award is scheduled for completion by October 6, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,961.10 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,398.61 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 500 mg tablets (60-count units) on June 12, 2025, with completion scheduled for June 13, 2025. The contract utilizes firm fixed price terms and is not designated as a set-aside award, indicating it was competitively awarded. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,543.70 by the Defense Logistics Agency on September 11, 2025, with completion expected by October 2, 2025. The contract calls for the supply of Lynparza 100 mg tablets in quantities of 60 units, a targeted oncology medication used in cancer treatment. The award was made on a firm fixed-price basis without set-aside designation, indicating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carbamazepine ER 400 mg tablets (100-count units) with a ceiling value of $1,242.64. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $43,070.67 to AmerisourceBergen Drug Corp for the supply of Xalkori 250 mg capsules (60-count units) on September 12, 2025, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...